Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase1,21Escherichia coli thymidylate synthase numbering is used unless otherwise noted.2PDB coordinates have been deposited with the RCSB with accession ID: 1JG0.  by Fritz, Timothy A et al.
Predicting and harnessing protein £exibility in the design of
species-speci¢c inhibitors of thymidylate synthase1;2
Timothy A. Fritz a, Donatella Tondi b, Janet S. Finer-Moore a, M. Paola Costi b; 3,
Robert M. Stroud a; *
aMacromolecular Structure Group, Departments of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94143-0448, USA
bDipartimento Di Scienze Farmaceutiche, Universita' degli Studi di Modena e di Reggio Emilia, 183 Via Campi, Modena, Italy
Received 29 March 2001; revisions requested 22 May 2001; revisions received 28 June 2001; accepted 16 July 2001
First published online 13 August 2001
Abstract
Background: Protein plasticity in response to ligand binding
abrogates the notion of a rigid receptor site. Thus, computational
docking alone misses important prospective drug design leads.
Bacterial-specific inhibitors of an essential enzyme, thymidylate
synthase (TS), were developed using a combination of computer-
based screening followed by in-parallel synthetic elaboration and
enzyme assay [Tondi et al. (1999) Chem. Biol. 6, 319^331].
Specificity was achieved through protein plasticity and despite the
very high sequence conservation of the enzyme between species.
Results : The most potent of the inhibitors synthesized, N,O-
didansyl-L-tyrosine (DDT), binds to Lactobacillus casei TS (LcTS)
with 35-fold higher affinity and to Escherichia coli TS (EcTS) with
24-fold higher affinity than to human TS (hTS). To reveal the
molecular basis for this specificity, we have determined the crystal
structure of EcTS complexed with DDT and 2P-deoxyuridine-5P-
monophosphate (dUMP). The 2.0 Aî structure shows that DDT
binds to EcTS in a conformation not predicted by molecular
docking studies and substantially differently than other TS
inhibitors. Binding of DDT is accompanied by large rearrange-
ments of the protein both near and distal to the enzyme’s active
site with movement of CK carbons up to 6 Aî relative to other
ternary complexes. This protein plasticity results in novel
interactions with DDT including the formation of hydrogen
bonds and van der Waals interactions to residues conserved in
bacterial TS but not hTS and which are hypothesized to account
for DDT’s specificity. The conformation DDT adopts when
bound to EcTS explains the activity of several other LcTS
inhibitors synthesized in-parallel with DDT suggesting that DDT
binds to the two enzymes in similar orientations.
Conclusions: Dramatic protein rearrangements involving both
main and side chain atoms play an important role in the
recognition of DDT by EcTS and highlight the importance of
incorporating protein plasticity in drug design. The crystal
structure of the EcTS/dUMP/DDT complex is a model system
to develop more selective TS inhibitors aimed at pathogenic
bacterial species. The crystal structure also suggests a general
formula for identifying regions of TS and other enzymes that may
be treated as flexible to aid in computational methods of drug
discovery. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Thymidylate synthase (TS) is an essential enzyme for
life. It catalyzes the formation of the DNA precursor thy-
midine-5P-monophosphate from the substrate 2P-deoxyur-
idine-5P-monophosphate (dUMP) and the cofactor 5,10-
methylene-5,6,7,8-tetrahydrofolate (mTHF). Because of
its critical function, considerable e¡ort has focused on
the design of TS inhibitors for the treatment of cancer
[2,3]. Less attention has been directed toward the design
of species-speci¢c TS inhibitors aimed at treating diseases
caused by bacterial, fungal or opportunistic pathogens. In
part, the lack of research may be due to the highly con-
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served structure of the TS active site [4] which presents a
severe challenge for the design of inhibitors with a thera-
peutic level of discrimination for pathogen versus human
TS (hTS). However, given the rise in antibiotic resistant
bacteria [5], the relative host toxicity of treatments for
fungal infections and the poor therapies available for the
treatment of several opportunistic infections of immuno-
compromised individuals [6], the successful development
of pathogen-speci¢c TS inhibitors may o¡er an important
alternative to current antibiotic, antiparasitic and antifun-
gal medications.
Recently, a strategy to create novel TS inhibitors suc-
cessfully combined computer-based docking to the folate
binding site of TS followed by in-parallel chemical syn-
thetic elaboration and enzyme assay [1]. An initial lead
(dansyl hydrazine) was discovered from the Available
Chemicals Directory (W150 000 compounds) by applica-
tion of the program DOCK 3.5 [7,8] to a ternary complex
crystal structure of Lactobacillus casei TS (LcTS) that was
kept rigid during DOCK calculations. A small library of
molecules synthesized by introducing various chemical
‘modules’ to the dansyl hydrazine sca¡old was created
and assayed for inhibition and speci¢city. The most potent
of the inhibitors in the library, N,O-didansyl-L-tyrosine
(DDT), was also the most speci¢c for the bacterial LcTS
relative to hTS.
We show that DDT inhibits Escherichia coli TS (EcTS)
with an a⁄nity similar to its a⁄nity for LcTS suggesting
that DDT may interact with residues conserved between
the bacterial LcTS and EcTS but not hTS. To understand
the mechanism of inhibition and the basis of speci¢city of
DDT we determined the crystal structure of EcTS bound
to DDT and dUMP. We chose EcTS rather than LcTS
since, unlike LcTS, EcTS readily cocrystallizes in ternary
complexes with dUMP and cofactor or cofactor analogs.
We show that DDT binds to the active site in a manner
unlike that predicted from DOCK studies and induces
large rearrangements of residues both within and remote
from the active site. These rearrangements result in inter-
actions between DDT and conserved residues in bacterial
TS but not hTS, which may explain DDT’s speci¢city. Our
results suggest that a combination of structure-based frag-
ment selection combined with experimental elaboration
and speci¢city assays can be an e¡ective path to using
protein plasticity for the design of drug leads.
2. Results
2.1. Inhibitor speci¢city
The synthetic elaboration of dansyl hydrazine (the ini-
tial DOCK lead) to O-dansyl-L-tyrosine and ¢nally DDT
was re£ected by a steady progression of improved inhib-
itor a⁄nity and speci¢city for LcTS versus hTS where
speci¢city is de¢ned as the IC50 for hTS divided by the
IC50 for bacterial TS [1] (Table 1). In contrast, nearly all
of the improvement in inhibitor a⁄nity and speci¢city for
EcTS was the result of the single-step transition from
O-dansyl-L-tyrosine to DDT with O-dansyl-L-tyrosine
showing essentially the same a⁄nity as dansyl hydrazine
for EcTS. The ¢nal level of speci¢city of DDT for LcTS
was 35 and for EcTS was 24 relative to hTS. Compared to
the lead molecule dansyl hydrazine, DDT’s speci¢city rep-
resents an improvement of 400- and 800-fold for LcTS and
EcTS, respectively. DDT’s speci¢city for EcTS and LcTS
is at least 100-fold greater than that of ZD1694 (Table 1),
an antifolate recently approved for the treatment of colo-
rectal cancer.
2.2. X-ray crystal structure
The EcTS/dUMP/DDT structure crystallizes as a full
physiologic dimer in the asymmetric unit. The crystallo-
graphic data and re¢nement statistics are presented in Ta-
ble 2. Although the two monomers of the enzyme are
structurally unique, the di¡erences between them are min-
imal and mainly con¢ned to three loop regions consisting
of residues 18^23, 81^89 and 103^106. The rms deviation
(rmsd) of CK carbons of the aligned monomers is 0.5 Aî .
A simulated annealing omit map of the ¢nal re¢ned struc-
ture shows well de¢ned density for dUMP and DDT in
both active sites (Fig. 1). Hydrogen bonds and van der
Waals interactions between dUMP and the protein and
between DDT and the protein are the same in both active
sites. Electron density of the C-terminal isoleucine (Ile
264) was nearly absent so this residue was omitted from
the structure as were the side chains of Arg 21 and Arg
107. Because of the structural similarity of the two mono-
mers and bound ligands, detailed analysis for only one of
the monomers is presented.
2.3. Binding and orientation of dUMP
Hydrogen bonds and van der Waals interactions to the
pyrimidine and ribose rings of dUMP in the EcTS/dUMP/
DDT structure are similar to those in other EcTS ternary
complexes [9,10]. Despite the preservation of these inter-
actions, dUMP C6 and the active site cysteine (Cys 146) SQ
are separated by s 3 Aî which precludes the formation of
the covalent bond between these two residues. The crea-
tion of this bond represents an early step in the catalytic
mechanism of the enzyme. Cys 146 SQ adopts two confor-
mations, one in which it is hydrogen-bonded to the car-
bonyl oxygen of Ser 167 and the other in which it is
hydrogen-bonded to water 785.
Of four arginine residues of the TS homodimer nor-
mally hydrogen-bonded to the phosphate group of
dUMP, two (Arg 21A, Arg 166A) are contributed by
one monomer and two (Arg 126B, Arg 127B) by the sec-
ond monomer [9]. In the EcTS/dUMP/DDT structure,
only hydrogen bonds from two, Arg 166A and Arg
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126B, are preserved. One of the unbound arginines (Arg
21A) is within a loop that has been displaced up to 6 Aî
from its normal ternary complex location. The other un-
bound arginine (Arg 127B) lies in two conformations hy-
drogen-bonded via water molecules to the carbonyl of Leu
138 in one orientation and the amide nitrogen of Ile 129 in
the second. The three hydrogen bonds normally contrib-
uted to the phosphate by these arginines have been re-
placed by water molecules 547, 581 and 590. Hydrogen
bonding to the phosphate by an additional residue (Ser
167) is also preserved as in other ternary complexes [10].
2.4. Binding and orientation of DDT
The binding of DDT to EcTS is quite unique and unlike
that seen in other ternary EcTS/dUMP/antifolate com-
Table 1
Structures, IC50 values and speci¢cities of TS inhibitors
*Atom and ring naming is shown for DDT. 2Numbers in parentheses are speci¢city indices de¢ned as the IC50 for the human enzyme divided by the
IC50 for bacterial TS. VFor compounds 4^7, the R group (O-dansyl-L-tyrosine for each) is linked via the amine moiety of O-dansyl-L-tyrosine and the
data for these compounds were previously reported [1]. 3ND = not determined. uData for ZD1694 are from [19].
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plexes [9^11]. A comparison of DDT bound to EcTS to
the antifolate ZD1694 bound to EcTS and hTS is shown
in Fig. 2. The O-dansyl moiety of DDT binds to the site
normally occupied by the quinazoline group of antifolates
(or the pterin ring of cofactor) but in a substantially di¡er-
ent orientation. The location of the naphthyl ring of the
O-dansyl group positions N1* of the dimethyl amino
group within 0.2 Aî of the site normally occupied by a
water molecule (water 580, Fig. 2B) that is critical for
mediating the closing of the carboxyl-terminus. In EcTS
ternary complexes with cofactor or cofactor analogs this
water forms simultaneous hydrogen bonds to a ring nitro-
gen of the quinazoline group or the natural substrate
mTHF and the carbonyl oxygen of the penultimate resi-
due Ala 263 [9,10,12]. The steric bulk of the two methyl
groups on N1* of DDT precludes the interaction of DDT
N1* with Ala 263 O and thus keeps the enzyme in an
‘open’ or apoenzyme-like conformation.
The only direct hydrogen bond between the enzyme and
DDT is from non-conserved Thr 78 OQ1 to DDT O2 (Fig.
2A). All other hydrogen bonds between the enzyme and
DDT are mediated via water molecules. DDT O2 forms
additional hydrogen bonds to non-conserved Ser 54 OQ
and Thr 78 N via water 549. DDT N1 is hydrogen-bonded
to Glu 58 OO1 via water 440 and DDT N1* forms a
hydrogen bond of relatively poor geometry to O5* of
dUMP via water 797. Two new water molecules (waters
556 and 737) not present in other EcTS ternary complexes
help to stabilize DDT binding by forming aromatic hydro-
gen bonds to the ligand. Water 556 forms a hydrogen
bond between the edge of the A ring of the O-naphthyl
group and the face of the indole ring of Trp 80 while water
737 forms a hydrogen bond with the face of the A ring of
the O-naphthyl group and the edge of the A ring of the
N-dansyl moiety of DDT. A summary of the hydrogen
bonds between the protein and DDT is shown in Table 3.
Table 2
X-ray di¡raction data and re¢nement statistics
Resolution (Aî ) 50^2.0
Unit cell dimensions (Aî ) a = 53.797, b = 87.062, c = 127.461
Space group P212121
Molecules/asymmetric unit 1
Observed re£ections 333 240
Unique re£ections 41 069
Completeness 99.6%
Rmerge (50^2.0 Aî ) 9.7%
Rwork 21.2%
Rfree 25.0%
Total atoms 4848
Water molecules 398
rmsd bonds (Aî ) 0.009
rmsd angles (‡) 1.7
Average B-factor 28.6 (33.5 water, 36.0 ligands)
Fig. 1. DDT and dUMP are well de¢ned and oriented in the active site. A simulated annealing (Fo3Fc)Kcalc omit electron density map was calculated
after omitting the ligands from the active site. The re¢ned structures of dUMP and DDT are superimposed on the electron density map which is con-
toured at 3 sigma. DDT and dUMP are similarly oriented in the second active site.
Table 3
DDT hydrogen bonding to EcTS
Protein/dUMP/H2O residue and atoms DDT atom(s) Distance(s)a
Thr 78 OQ O2 3.2
Thr 78 N (Wat 549) O2 2.9, 2.6
Ser 54 OQ (Wat 549) O2 2.9, 2.6
Glu 58 OO1 (Wat 440) N1 2.8, 2.9
Trp 80 ring (Wat 556) A ring 3.5, 4.1
dUMP 05* (Wat 797) N1* 3.1, 3.0
aWhen two distances are listed, the ¢rst distance is from the protein (or
dUMP) atom to the water molecule and the second distance is from the
water to the DDT atom. Aromatic hydrogen bond distances are taken
from the closest point on the aromatic ring to the water molecule.
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DDT is relatively hydrophobic and the majority of the
interactions it forms with EcTS re£ect this chemistry. Of
the 10 protein residues contacting DDT, seven form purely
van der Waals interactions with the ligand (Fig. 3A). The
combination of the phenyl ring and N-dansyl group of
DDT occupy the region of the active site ¢lled by the
p-aminobenzoic acid (PABA) moiety of antifolates (exem-
pli¢ed by the interactions of the thiophene ring of
ZD1694, Fig. 3B). The phenyl ring and A* ring of the
N-dansyl group form favorable aromatic stacking interac-
tions with each other and, in turn, these rings are sand-
wiched between the hydrophobic residues Leu 172 and Ile
79. The binding pocket for the phenyl and N-dansyl moi-
eties is completed at the bottom of the active site by res-
idues Phe 176 and Ile 55 and at the surface of the active
site by Val 262. Phe 176 has swung from its conformation
in the folate-bound complex to permit contact of DDT
with Ile 55. Ile 55 adopts a conformation not seen in other
EcTS ternary complexes to make van der Waals contact
with C7 and C8 of the N-dansyl group while the DDT
phenyl ring forms van der Waals interactions with Val
262. Ile 55 and Val 262 are conserved between EcTS and
LcTS but are substituted by Val and Met, respectively, in
hTS (Figs. 2A and 3A).
In addition to Ile 55 and Val 262, a third residue that
interacts with DDT and is conserved between EcTS and
Fig. 2. Conservation and variation of active site protein structure and ligand interactions of EcTS and hTS. Aligned monomers (note the similar orien-
tations of dUMP) of EcTS/dUMP/DDT (A), EcTS/dUMP/ZD1694 (B) and hTS/dUMP/ZD1694 (C) complexes are shown. The full dimeric structures
were aligned to each other using the program LSQMAN based upon a core set of residues de¢ned by di¡erence distance matrix analysis [17]. DDT,
ZD1694 and dUMP are shown in black and active site residues are shown in gray. Only those portions (backbone or side chain) of protein residues in-
teracting with ligands are shown for clarity purposes. Hydrogen bonds are shown as dashed lines and water molecules are represented by numbers with-
out a single letter pre¢x. In A, residues contacting DDT which are conserved between EcTS and LcTS (I55, W83 and V262) but which di¡er from
those of hTS are underlined with a solid line and the corresponding hTS residues are shown in parentheses. Residues interacting with DDT which di¡er
between EcTS, LcTS and hTS are underlined with a dashed line and the residues in parentheses indicate the LcTS followed by the hTS residue. All oth-
er residues in A are conserved across each of the three TS species. The EcTS numbering system is used in each panel except for waters which retain the
numbering of the corresponding structure.
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Fig. 3. Schematic diagram comparing the binding to EcTS of DDT (A) and ZD1694 (B). Hydrogen bonds are shown as green dashed lines and hydro-
phobic interactions are indicated by red ‘eyelashes’. In A, non-conserved residues are shown as multiple listings with the ¢rst (numbered) being the
EcTS residue, the second the LcTS residue and the residue in parentheses the hTS residue. Residues conserved between EcTS and LcTS but not hTS
(the ‘speci¢city residues’) are indicated by the brackets. Waters are shown in cyan. The ¢gure was generated using the program Ligplot [37].
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LcTS but not hTS is Trp 83 (Figs. 2A and 3A). EcTS Trp
83 is Asn in hTS. The DDT C9* methyl group makes van
der Waals contact with the side chain of Trp 83 which is
rotated by W180‡ relative to other EcTS ternary com-
plexes. The Trp 83 side chain also orients itself to form
van der Waals contacts to two other LcTS-speci¢c inhib-
itors as observed in the crystal structures of these inhib-
itors in ternary complexes with LcTS [13]. In contrast, the
corresponding Asn side chain in hTS ternary complexes
forms hydrogen bonds or electrostatic interactions with
antifolates. The N1 and N7 atoms of the pyrrolo[2,3-d]py-
rimidine ring of the antifolate LY231514 form hydrogen
bonds to the side chain of this Asn residue (Sayre et al.,
J. Mol. Biol., in press) while the positive edge potential of
the 2-methyl quinazoline ring of ZD1694 interacts with
OD1 of the Asn residue [14] (Fig. 2C).
2.5. Comparison of the crystal and modeled structures of
DDT binding
A predicted binding mode of DDT to LcTS has been
described [1]. Fig. 4 shows a comparison of the docked
orientation of LcTS-bound DDT and the crystal structure
of DDT bound to EcTS. This comparison is valid since
both the current EcTS structure and the LcTS structure
used for the modeling [15] are ‘open’ forms of the enzyme.
The rmsd between the two structures for the CK atoms of
the 10 residues interacting with DDT is 1.1 Aî . DOCK was
roughly successful in its prediction that the O-dansyl and
phenyl rings of DDT would bind to the regions of the
active site normally occupied by the quinazoline and
PABA moieties, respectively, of antifolates [1]. However,
DDT interacts more deeply in the active site than pre-
dicted by DOCK due to the substantial and unanticipated
protein rearrangements elicited by DDT binding. The
crystal and modeled structures diverge most in the loca-
tion of the N-dansyl moiety. The active site opens up in
the region where the N-dansyl ring was predicted to bind;
consequently DOCK found several high scoring confor-
mations for the N-dansyl moiety. The docked orientation
of this dansyl group extends away from the active site and
many orientations bury this dansyl ring against non-polar
surface patches in the LcTS structure, such as that de¢ned
by LcTS residues Ala 309 and Ile 310 (EcTS Gly 257 and
Ile 258, respectively), and that de¢ned by LcTS residues
Leu 56, Ile 81 and the CL of His 80 (EcTS Ser 54, Ile 79
and Thr 78, respectively). A more extensive search of
DDT conformational space than the 500 structures ini-
tially used may have more closely predicted the conforma-
tion of DDT bound to EcTS.
It was noted that no single modeled conformation of
DDT could explain the structure^activity relationships
(SARs) of the other inhibitors synthesized in-parallel
with DDT [1]. The orientation of DDT revealed by the
crystal structure explains the observed binding a⁄nity of
many of these inhibitors, several of which are shown in
Table 1. The compound containing a dibutyl amino group
in place of the N-dansyl dimethyl amino atoms has an
IC50 at least 15-fold higher than DDT. The crystal struc-
ture shows that this hydrophobic dibutyl amino structure
would be unfavorably packed into a hydrophilic pocket
lined by residues Asn 177, His 147, Glu 58, Ser 180 and
the pyrimidine base of dUMP. Inhibitors with bulkier sub-
stituents than the N-dansyl moiety, such as the 4P-(di-
methylamino)azobenzene-4-sulfonyl group, had IC50 val-
ues at least 15-fold higher than DDT. These larger,
hydrophobic groups would have di⁄culty being accommo-
dated within and, thus, would likely be forced from the
active site and exposed to the unfavorable environment of
bulk solvent. It was also noted that the docked structures
could not explain why sulfonamide compounds always
bound better (6^15-fold) than their amide counterparts.
The current structure suggests that the substitution of
the N-dansyl sulfonyl group with a carbonyl would be
unfavorable due to the tendency of the amide bond to-
wards planarity. This geometry would again force the
amide-linked rings out of the active site, a situation that
could not be overcome by torsions about adjacent bonds.
Though these inhibitors (including DDT), when bound to
LcTS, may adopt dissimilar conformations compared to
EcTS-bound DDT, the ability of the crystal structure to
explain the SAR of several compounds suggests that the
inhibitors do tend to bind in a similar conformation as
EcTS-bound DDT with the N-linked ring system (either
a single or double ring) stacked above the phenyl ring of
DDT.
Fig. 4. The crystallographic orientation of DDT bound to EcTS di¡ers from the modeled conformation of DDT bound to LcTS. The LcTS/dUMP/
DDT complex is shown in gray and the EcTS/dUMP/DDT complex is shown in yellow (ribbon) and atomic colors (DDT, dUMP).
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2.6. Protein plasticity
Many enzymes reorient active site residues to permit the
binding of non-native ligands [16]. The conformation
adopted by DDT when bound to EcTS presents an un-
usual structure to be accommodated by the EcTS active
site. The active site residue plasticity induced by DDT
binding is shown in Fig. 5A. Signi¢cant reorientation of
Fig. 5. DDT binding induces dramatic side chain and backbone plasticity. A: Divergent stereo view showing the plasticity of the side chains of active
site residues between the EcTS/dUMP/DDT and EcTS/dUMP/ZD1694 structures. DDT and dUMP are shown in yellow, active site residues from the
EcTS/dUMP/DDT structure are shown in atomic colors and active site residues from the EcTS/dUMP/ZD1694 structure are shown in gray. B: Diver-
gent stereo view of aligned monomer backbones of the EcTS/dUMP/DDT (black and red) and EcTS/dUMP/ZD1694 (green) structures. The orientation
of the structure is the same as that in A and DDT and dUMP are shown in yellow. Residues in red mapped onto the EcTS/dUMP/DDT backbone
structure are approximately centrally located residues of protein segments which shift by s 1Aî between the two structures. The location of the J-helix
(J) is also indicated. C: Di¡erence in CK position between aligned structures of the EcTS/dUMP/DDT and EcTS/dUMP/ZD1694 complexes with the
position of residues shown in B indicated.
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the side chains of Ile 55, Thr 78, Ile 79, Trp 83, Leu 172,
Phe 176 and Val 262 as well as translational motions of
Ser 54, Glu 58 and Trp 80 can be seen relative to the
EcTS/dUMP/ZD1694 complex. The rmsd between the
EcTS/dUMP/DDT and EcTS/dUMP/ZD1694 structures
for all atoms of the active site residues contacting DDT
is 2.0 Aî .
Several structural elements of EcTS make concerted,
segmental movements upon binding cofactor [9]. In addi-
tion to active site residues, binding of DDT to EcTS is
accompanied by large rearrangements of the protein distal
to the active site (Fig. 5B,C) and it is these same protein
segments that shift during segmental accommodation (Fig.
6C,D). Thus, DDT has harnessed the protein £exibility
inherent in the enzyme’s catalytic mechanism. However,
the movements evoked by DDT binding are in roughly
the opposite direction to those typically observed for ter-
nary complex formation such that the structure of the
EcTS/dUMP/DDT complex more resembles the ‘open’
or apo conformation of EcTS [17] rather than ternary
EcTS complexes with antifolates (or cofactor) and
dUMP. The opening of the active site is primarily due
Fig. 6. Ligand-induced, main chain plastic accommodation of EcTS. Individual panels represent the positional di¡erence between corresponding CK car-
bons of the EcTS/dUMP/mTHF structure [12] aligned with (A) the EcTS/dUMP/ZD1694 [10], (B) the EcTS/dUMP/BW1843U89 [11], (C) the EcTS/
dUMP/DDT or (D) the apo EcTS structure [17]. Only one monomer of each of the aligned structures is shown. D represents the structural changes
known as segmental accommodation that take place upon cofactor binding to TS.
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to the combination of the phenyl and N-dansyl moieties of
DDT acting as a wedge between residues Leu 172 and Ile
79 (Fig. 5A). Leucine 172 is at the beginning of the J-helix
which is buried at the center of the monomer and forms
extensive interactions with 11 distinct protein segments
(including three of the ¢ve L-sheets which form the dimer
interface) that tend to ¢x the helix in place. Despite these
restraining interactions, the CK of Cys 192 at the C-termi-
nus of the J-helix is shifted by 0.5 Aî and the CK of Leu
172 near the N-terminus of the helix is shifted by 1.1 Aî .
Compared to the J-helix, the in£uence of the phenyl/N-
dansyl wedge on residues 68^90 is more pronounced since
these residues lie at the surface of the enzyme and are less
constrained than those of the J-helix. Binding of the anti-
folate BW1843U89 to EcTS also reorders residues within
this region [11,18] but the reorganization caused by DDT
is more extensive and results in further distortions of the
main chain geometry (Fig. 6B,C). In contrast to the main
chain reorganization caused by BW1843U89 and DDT,
accommodation by EcTS of the antifolate ZD1694 in-
volves little change relative to the EcTS/dUMP/mTHF
structure (Fig. 6A). While the apo EcTS and EcTS/
dUMP/DDT ternary structures are more similar to each
other than the EcTS/dUMP/DDT complex is to other
EcTS ternary structures, substantial di¡erences still remain
(Fig. 6C,D).
Shifts in four other protein segments can be understood
as a consequence of the e¡ect of the phenyl/N-dansyl
wedge of DDT upon residues 68^90 and the prevention
of the carboxyl-terminus closing by the O-dansyl dimethyl
amino group (Fig. 5B). Residues 134^148, which include
the catalytic Cys 146, shift to maintain their interface with
residues 68^90. Similarly, steric clashes with the methyl
groups on DDT N1* displace the carboxyl-terminus
whose movements are relayed to residues 208^225. In
turn, the shift in residues 208^225 is transmitted via
main chain hydrogen bonding to residues Gly 25 and
Leu 27 in the loop containing Arg 21 whose CK is dis-
placed by 6 Aî from its typical ternary complex location.
Residues 208^225 also form hydrogen bonds and van der
Waals interactions with Thr 46 and Thr 47 which are at
the beginning of a short segment of residues (44^55) con-
taining Ile 55. Thus, the shift in residues 208^225 is re-
sponsible for the positioning of Ile 55 and its unique in-
teractions with DDT. In fact, each of the residues
conserved between EcTS and LcTS but not hTS (Ile 55,
Trp 83 and Val 262) belongs to segments of the protein
undergoing substantial reordering resulting from the struc-
tural changes evoked by DDT binding.
3. Discussion
3.1. Selectivity of DDT
Protein plasticity increases the probability of developing
novel drugs or improving the properties of established li-
gands by increasing their speci¢city and/or decreasing their
toxicity. A relatively simple approach was used to success-
fully create TS inhibitors showing a remarkable level (con-
sidering the high sequence conservation of TS between
species) of speci¢city for bacterial TS versus hTS [1]. By
combining computer-based methods for ¢nding initial
leads with in-parallel synthetic elaboration and selectivity
assay, a lead molecule, DDT, was designed which displays
a 35-fold preference for binding to LcTS relative to hTS
and a 24-fold preference for binding to EcTS relative to
hTS. In total, fewer than 40 molecules were synthesized
leading to DDT. Structural information usefully con-
strained the diversity available in the synthetic explora-
tions, leading rapidly to more potent inhibitors. Thus,
this method avoids the large-scale combinatorial approach
in favor of a structure-based, focused library design.
The crystal structure of the EcTS/dUMP/DDT complex
suggests that the molecular basis of DDT’s bacterial spe-
ci¢city may be achieved primarily from van der Waals
contacts with the ‘speci¢city residues’ (Ile 55, Trp 83 and
Val 262) conserved between EcTS and LcTS but not hTS.
Hydrogen bonding to DDT seems unlikely to account for
its bacterial speci¢city since hydrogen bonds to DDT in-
volve either the conserved Glu 58 or residues that di¡er
between EcTS, LcTS and hTS (Ser 54 and Thr 78) (Fig.
2A). Direct evidence that hydrogen bonds do not necessa-
rily promote bacterial speci¢city comes from the EcTS/
dUMP/ZD1694 and hTS/dUMP/ZD1694 structures. Hy-
drogen bonding of ZD1694 to EcTS and hTS is very sim-
ilar and involves both EcTS Ser 54 and hTS K78 (Fig.
2B,C) yet ZD1694’s a⁄nity for hTS is 6^10-fold greater
than for EcTS or LcTS [19]. Four of the seven residues
making hydrophobic contact with DDT (Ile 79, Leu 172,
Gly 173 and Phe 176) are completely conserved between
EcTS, LcTS and hTS and would also seem to o¡er no
obvious mechanism of ligand discrimination between bac-
terial TS and hTS. Mutational analysis of the ‘speci¢city
residues’ in EcTS, LcTS and hTS coupled with binding
studies may aid in testing this hypothesis.
The argument for the mechanism of speci¢city assumes
that DDT binds in similar orientations to each of the three
enzymes. Evidence favoring this hypothesis is the ability of
the EcTS-bound conformation of DDT to explain the
SAR of dansyl tyrosine derivatives for LcTS as discussed
above. Data suggesting that DDT may bind similarly to
EcTS and hTS is provided by the crystal structures of
EcTS and hTS bound to the antifolates ZD1694 and
LY231514. The protein structure corresponding to each
of these ligands is remarkably similar (Fig. 2B,C, Sayre
et al., J. Mol. Biol., in press) indicating that EcTS and
hTS conform to a given ligand in very similar ways. Crys-
tal structures of the LcTS/dUMP/DDT and hTS/dUMP/
DDT complexes would resolve the question of whether
DDT binds similarly to the three species of TS.
DDT displays similar a⁄nity toward EcTS and LcTS
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(Table 1) even though the two enzymes are only 51%
identical at the level of primary protein sequence. EcTS
shares greater homology with TS from several pathogenic
organisms including Shigella £exneri (98% identity), Neis-
seria gonorrhoeae (71% identity), Neisseria meningitidis
(71% identity), Pseudomonas aeruginosa (69% identity),
and Mycobacterium tuberculosis (66% identity). The three
‘speci¢city residues’ (Ile 55 Trp 80, Val 262) are conserved
among all these species, and all three di¡er at these posi-
tions in hTS. Thus, though EcTS is not itself a drug target,
it is likely to be similar enough in structure to serve as an
excellent model for TS from these pathogenic organisms.
Indeed, the EcTS structure was successfully used as a
model for hTS in anticancer drug development e¡orts at
Agouron Pharmaceuticals [20,21].
DDT represents a novel sca¡old suitable for further
structure-based design of inhibitors that achieve a thera-
peutic level of speci¢city for bacterial TS versus hTS. In-
teractions of DDT with Trp 83 could be optimized by
substitution of the naphthyl moiety of the O-dansyl group
by phenanthrene whose extra ring could form favorable
stacking interactions with the Trp 83 side chain. Addition-
ally, a small hydrophobic substituent such as a methyl
group attached to the C7 or C8 atoms of the N-dansyl
ring might improve interactions with Ile 55. The novel
water molecule water 737 lies 3.8 Aî from DDT C3* and
could be displaced by a hydroxyethyl, thioethyl or pro-
panenitrile group (W3.6 Aî in length) attached to this
atom. One of these chemical moieties placed on DDT
C7 might similarly displace the novel water 588 which
lies 3.7 Aî from this atom. The entropic gain resulting
from the displacement of a single bound water molecule
typically results in a⁄nity increases of 2^20-fold (0.4^1.8
kcal/mol) [22] so the displacement of three water molecules
from the EcTS/dUMP/DDT structure could improve the
a⁄nity of DDT for bacterial TS. Whether the release of
these waters would increase DDT’s speci¢city in-parallel
with any gains in a⁄nity would need to be determined.
3.2. Rules for predicting ‘soft spots’ on the protein for
drug a⁄nity enhancement
The ability to reorient active site residues to accommo-
date diverse ligands is a characteristic of many proteins
[16] and algorithms for including side chain £exibility in
computer-based drug design have been described [23,24].
The capacity of an active site to ‘£ow’ around the surface
of a novel ligand often involves hydrophobic residues or
the hydrophobic areas of polar residues. Within the EcTS
active site, the side chains of many of the residues that
interact with DDT are substantially reordered relative to
their positions in other EcTS ternary complexes (Fig. 5A)
and most of these (seven of 10) are hydrophobic. In par-
ticular, Ile 55, Ile 79, Trp 83, Leu 172, Phe 176 and Val
262 accommodate DDT binding through a reorientation
of side chain atoms. The ability of some of these residues,
notably Ile 79, Leu 172 and Phe 176, to reorient in re-
sponse to ligand binding has previously been found to
occur in other ternary complexes of TS [10,11,18,25].
Thus, groups of hydrophobic moieties from residues
near to the target site of binding need to be considered
as potentially malleable for purposes of drug discovery.
We developed an algorithm for selecting an optimized
set of these residues, and screening all possible rotamers
for a subset that dramatically improves the scoring of drug
leads [26].
In addition to side chain reordering, dramatic main
chain rearrangements also occur upon DDT binding
(Figs. 5B,C and 6C). The main chain of residues 68^90
undergoes some of the most signi¢cant movements to ac-
commodate DDT. These residues also shift to accommo-
date the binding of the antifolate BW1843U89 (Fig. 6B,C),
and other antifolates, though they move in di¡erent ways.
Understanding which regions of a peptide chain will read-
ily move to accommodate ligand binding, and which do
not, is key to advancing beyond the ‘rigid receptor hy-
pothesis’. The ability to predict the potential manifold of
conformers of this segment, for which we have nearly 100
liganded TS structures, can help to identify which regions
of other proteins may display plastic properties. Such an
algorithm could therefore be important to structure-based
lead development that seeks to exploit such accommodat-
ing regions.
One measure of protein £exibility used for identifying
main chain mobility is the relative magnitude of atomic B-
factors, as used for example in T4 lysozyme [27]. It was
noted that cavity-containing mutants of T4 lysozyme had
greatly increased main chain B-factors for residues in the
F-helix upon binding various ‘ligands’ within the cavity.
However, main chain B-factors are not reliable predictors
of the £exibility of EcTS residues 68^90 (Table 4). Indeed,
Table 4
EcTS main chain atomic B-factors (Aî 2)a
Complex Monomer Residues
68^90 Other accessibleb
EcTS/dUMP/DDT A 35.0 þ 11.3 35.0 þ 23.9
B 29.9 þ 11.5 41.6 þ 23.9
EcTS/dUMP/CB3717 A 13.8 þ 4.4 14.2 þ 4.7
B 26.1 þ 4.0 24.9 þ 6.9
EcTS/dUMP/ZD1694 A 19.5 þ 5.4 21.2 þ 4.3
B 31.8 þ 5.2 27.8 þ 6.5
EcTS/dUMP/BW1843U89 A 19.5 þ 9.0 17.1 þ 6.6
B 41.8 þ 5.5 27.7 þ 7.2
EcTS/dUMP/mTHF A 16.3 þ 5.7 17.6 þ 4.7
B 32.7 þ 5.5 25.0 þ 7.4
Apo EcTSc A 16.6 þ 4.6 16.0 þ 5.4
aComparison of the average B-factors (with standard deviation) of resi-
dues 68^90 to residues with similar solvent accessibility of ¢ve EcTS ter-
nary complexes [9^12] and apo EcTS [17].
b‘Other accessible’ residues have similar solvent accessibility compared
to residues 68^90 and are de¢ned as described in Section 5.
cThe apo EcTS structure contains a single monomer in the asymmetric
unit.
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the atomic B-factors re£ect the amplitude of motion in the
protein chain around its energy minimum position, and
may not re£ect the space or constraints beyond the
V1 Aî amplitude of vibration range. Comparison of the
main chain B-factors of residues 68^90 to residues with
comparable solvent accessibility in three EcTS ternary
complexes (EcTS/dUMP/DDT, EcTS/dUMP/CB3717,
EcTS/dUMP/ZD1694) and in apo EcTS shows that the
B-factors for both sets of residues are not signi¢cantly
di¡erent (Table 4). The same is true for the A monomers
of the EcTS/dUMP/BW1843U89 and EcTS/dUMP/mTHF
structures. Only for the B monomers of these latter two
structures are the main chain B-factors of residues 68^90
and residues of comparable solvent accessibility signi¢-
cantly di¡erent. Ideally, one would want to identify plastic
regions from a single crystallographic structure. Therefore,
another means of identifying regions of potential protein
£exibility for use in drug design is needed.
For the many liganded structures of EcTS, better indi-
cators of plasticity are the presence of few ‘sca¡olding’
hydrogen bonds within and between protein segments,
and high solvent accessibility of these segments (Table
5). Here, a protein segment is de¢ned as a covalently con-
tiguous sequence of amino acids of arbitrarily de¢ned
length. An inter-segment hydrogen bond is one between
the segment and residues outside of it. The ‘wedge’ of
DDT acts between Leu 172 within the J-helix and Ile 79
which lies within the segment comprised of residues 68^90.
Why are residues 68^90 able to accommodate DDT while
the J-helix remains relatively ¢xed in place? The J-helix
has 80% of its surface area solvent-inaccessible and forms
the core of the TS monomer by making contacts with
11 distinct protein segments. These contacts include 14
inter-segment hydrogen bonds (six main chain/main chain,
four main chain/side chain and four side chain/side chain)
that tend to ¢x the J-helix in place (Table 5).
In contrast, in the EcTS/dUMP/DDT structure residues
68^90 are mostly devoid of secondary structure and lie at
the surface of the enzyme with only 33% of their total
surface area buried. Twenty-two of the 23 residues in the
68^90 sequence form no main chain/main chain hydrogen
bonds to residues outside this sequence (Table 5). The
single residue (Leu 90), which does form an inter-segment
main chain/main chain hydrogen bond, lies at the end
(‘hinge point’) of the sequence and so does little to con-
strain the movement of the remaining residues. Three
residues (Tyr 71, Asn 75, and Trp 80) in 68^90 form in-
ter-segment side chain/main chain or side chain/side chain
hydrogen bonds, that remain unbroken between the unli-
ganded and DDT-bound state. These hydrogen bonds
may restrict, and so help to de¢ne the available motion
of the 68^90 sequence. In addition, one hydrogen bond is
formed by Asn 76 as DDT binds. Therefore, of the resi-
dues in the inaccessible J-helix or those of the segment
surrounding and including Ile 79, the latter would be the
ones most likely to shift the most upon accommodating a
novel ligand. Residues 68^90 form similar numbers and
types of hydrogen bonds in the apo EcTS and EcTS/
dUMP/ZD1694 structures indicating that the hydrogen
bonding of these residues is structure independent. This
is important as it shows that these residues could have
been identi¢ed as being potentially plastic (evidenced by
low numbers of inter-segment hydrogen bonds and high
solvent accessibility) from any single EcTS structure.
The residues in the F-helix of apo T4 lysozyme are also
relatively solvent-accessible (54% buried surface area) and
form few inter-segment hydrogen bonds (Table 5). The
data in Table 5 suggest that two or fewer main chain/
main chain, three or fewer main chain/side chain and
two or fewer side chain/side chain hydrogen bonds permit
plastic adaptation of protein segments though these num-
bers may need re¢nement by analyses of additional protein
structures. The short length (eight residues) of the T4 ly-
sozyme F-helix indicates that substantially fewer than the
23 residues of the EcTS 68^90 segment may be capable of
plastic adaptation.
Identi¢cation of similar core and surface residues that
can interact with ligands in the target site on proteins is a
key element in identifying protein segments that can be
treated as malleable, for the purpose of site directed alter-
ations of a drug lead that would extend beyond the bind-
ing site if the site was treated as being relatively rigid. This
approach to identify main chain malleability is comple-
mentary to, and extends an approach that de¢nes an algo-
rithm for identifying side chains that can reorient to
accommodate changes in a drug lead [26].
Table 5
EcTS and T4 lysozyme inter-segment hydrogen bonding
Complex Residues Hydrogen bond type and numbera
Main/main Main/side Side/side
EcTS/dUMP/DDT 68^90 1 3 2
J-helix 6 4 4
EcTS/dUMP/ZD1694 68^90 2 2 1
Apo EcTS 68^90 2 3 2
T4 lysozyme 107^113 (F-helix) 2 1 1
aHydrogen bonds between residues 68^90 or the J-helix in the indicated EcTS structures or the F-helix of T4 lysozyme and other protein segments were
counted and categorized as either main chain/main chain, main chain/side chain or side chain/side chain.
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4. Signi¢cance
TS is an anticancer target due to its essential role in
DNA biosynthesis, a role which also makes TS an attrac-
tive target for species-speci¢c antibacterial, antifungal and
antiparasitic drugs that act on these species without inhib-
iting hTS. However, the high sequence conservation of TS
across species makes this goal a signi¢cant challenge. We
have developed bacterial-speci¢c competitive TS inhibitors
using a combination of computer-based screening followed
by in-parallel chemical synthesis and speci¢city assay
against a panel of pure TS from bacterial and human
species. The most potent and selective of these inhibitors,
DDT, binds to bacterial species L. casei and E. coli TS
with 35- and 24-fold higher a⁄nity, respectively, than to
hTS. The crystal structure of DDT with EcTS and dUMP
suggests that DDT’s speci¢city may derive from van der
Waals interactions, not hydrogen bonding, to ‘speci¢city
residues’ conserved in bacterial TS but not hTS. The con-
formation DDT adopts when bound to TS is unlike other
antifolates and the enzyme accommodates DDT binding
by undergoing substantial protein movements relative to
other EcTS ternary complexes. These movements occur
both near and far from the active site and permit the
interaction of DDT with the speci¢city residues. Examina-
tion of the structure suggests that the phenyl and N-dansyl
groups of DDT act as a wedge between residues Leu 172
and Ile 79 to reorder residues 68^90, a protein domain of
TS known to reorder to accommodate ligand binding. The
high solvent accessibility and relative scarcity of hydrogen
bonds formed between residues 68^90 and the remainder
of the protein may account for the plasticity of these res-
idues and suggests that solvent-accessible, ligand-contact-
ing segments of other proteins with few hydrogen bonds
(97) to the rest of the protein may exhibit plastic proper-
ties. The EcTS/dUMP/DDT structure also indicates that
targeted modi¢cations to DDT (such as the addition of
hydroxyethyl, thioethyl or propanenitrile groups to DDT
C3* or C7) to displace active site water molecules may
improve DDT’s a⁄nity for EcTS and possibly TS of
pathogens in which the speci¢city residues are conserved.
5. Materials and methods
5.1. Enzymology
LcTS [28], EcTS [29] and hTS [30] were expressed and puri¢ed
as described previously. Puri¢ed enzymes were stored at 380‡C
in 10 mM phosphate bu¡er (pH 7.0), 0.1 mM EDTA (LcTS,
EcTS, hTS) or at 320‡C in 20 mM potassium phosphate (pH
7.4), 20 mM L-mercaptoethanol, 5 mM dithiothreitol, 85% satu-
rated ammonium sulfate (EcTS). All enzymes were greater than
95% homogeneous as determined by SDS^PAGE. Kinetic experi-
ments were conducted as previously described [13,31]. Inhibitors
were purchased from commercial sources or synthesized as de-
scribed previously [1].
5.2. Crystallization
EcTS stored at 320‡C in 85% saturated ammonium sulfate was
dialyzed at 4‡C against 20 mM potassium phosphate (pH 8),
2 mM dithiothreitol, 1 mM EDTA before crystallization. Protein
solutions were prepared by diluting dialyzed enzyme to 0.26 mg/
ml (¢nal concentration) into a solution containing Tris^Cl
(10 mM ¢nal, pH 8.5), DDT (80 WM ¢nal), dUMP (1 mM ¢nal)
and dithiothreitol (5 mM ¢nal). This solution was incubated at
4‡C for 30^60 min to allow for ligand binding and then concen-
trated using a Centricon-30 to a ¢nal protein concentration of
6 mg/ml. Well bu¡er contained 18^20% polyethylene glycol 4000,
0.2 M sodium acetate, 0.1 M Tris^Cl (pH 8.5) and 5 mM dithio-
threitol. Protein solutions were mixed with an equal volume of
well bu¡er containing 1 mM dUMP, 80 WM DDT and crystals
were grown by hanging drop vapor di¡usion over 1 ml of well
bu¡er. Crystals grew in 3^5 days at room temperature. Crystals
were soaked in well bu¡er containing 1 mM dUMP, 80 WM
DDT, and 15% ethylene glycol for 2 h and then £ash-cooled by
plunging into liquid nitrogen. Di¡raction intensities were col-
lected at beamline 9-1 at the Stanford Synchrotron Radiation
Laboratory. A complete dataset (333 240 total observations)
was recorded from a single frozen crystal (60 WmU60 WmU500
Wm) using 1.0‡ oscillation images. Intensities from 135 frames
were integrated and scaled using the programs DENZO and
SCALEPACK [32] in space group P212121 with unit cell dimen-
sions a = 53.797 Aî , b = 87.062 Aî and c = 127.461 Aî to give 41 069
unique re£ections with an overall Rsym of 9.7% calculated on
intensities.
5.3. Structure solution and re¢nement
The structure was solved by molecular replacement using the
program AMoRe [33] and the reported ternary complex structure
of EcTS/dUMP/BW1843U89 [11] with the ligands and water
omitted from the model. The EcTS/dUMP/BW1843U89 model
gave higher correlation coe⁄cients and lower R-factors compared
to EcTS/dUMP/CB3717 and EcTS/dUMP/ZD1694 models.
Least-squares conjugate gradient minimization followed by
grouped B-factor minimization using the program CNS [34]
gave an R-factor of 31.2 (Rfree = 35.03) using all re£ections from
50 to 2.0 Aî . A di¡erence density electron map ((Fo3Fc)Kcalc)
calculated following the grouped B-factor re¢nement showed
clear electron density for dUMP and DDT in both active sites.
DDT and dUMP were modeled into the electron density using
the program O [35]. Repeated cycles of conjugate gradient and
B-factor minimization using CNS along with several trials of
simulated annealing and manual rebuilding using O resulted in
a ¢nal re¢ned structure with an Rfree of 25.0% and an Rwork of
21.2% (Table 2).
5.4. Structure analysis
Alignment of proteins was done using the LSQMAN software
based upon di¡erence distance matrix plots [17]. The residues
(E. coli numbering) used for alignment were 32^37, 110^120,
150^160, 180^190 and 197^202. Solvent accessibility was calcu-
lated using the program AREAIMOL from the CCP4 suite of
programs [36]. Residues of the EcTS/dUMP/DDT complex with
similar solvent accessibility to residues 68^90 were de¢ned as
CHBIOL 131 26-9-01 Cyaan Magenta Geel Zwart
Protein plasticity for drug design T.A. Fritz et al. 993
those lying within v 5 residue stretches with a buried surface area
9 50% and consisted of residues 1^24, 99^109 and 212^263.
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